Abstract
The use of medical implants is a cornerstone of modern medicine. All implants face, however, a number of challenges including infection and inflammation which cause many of them to fail. In addition, tissue engineering implants must also direct stem cell differentiation and tissue regeneration in order to work properly. These problems may be overcome using drugs that are delivered directly from the implant. For this to work the drugs have to be protected until they have performed their function, their release must be timed with when they are needed, they may have to affect specific regions of an implant only and some drugs must be delivered to specific sub-cellular locations in certain cells types. This chapter explores how various forms of nanotechnology may be employed to reach these goals and reviews many of the studies that have used nanotechnology for different implant mediated drug release applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Iskander Z, Harris JE (1977) A skull with a silver bridge to replace a central incisor. Ann Serv Antiq Egypte 62:85–90
Thurston AJ (2007) Pare and prosthetics: the early history of artificial limbs. ANZ J Surg 77(12):1114–1119
Sanan A, Haines SJ (1997) Repairing holes in the head: a history of cranioplasty. Neurosurgery 40(3):588–603
Merrill JP, Murray JE, Harrison JH, Guild WR (1956) Successful homotransplantation of the human kidney between identical twins. JAMA 160(4):277–282
Barnard CN (1968) Human cardiac transplantation. An evaluation of the first two operations performed at the Groote Schuur Hospital, Cape Town. Am J Cardiol 22(4):584–596
DeVries WC, Anderson JL, Joyce LD, Anderson FL, Hammond EH, Jarvik RK, Kolff WJ (1984) Clinical use of the total artificial heart. N Engl J Med 310(5):273–278
Bazaka K, Jacob MV, Crawford RJ, Ivanova EP (2012) Efficient surface modification of biomaterial to prevent biofilm formation and the attachment of microorganisms. Appl Microbiol Biotechnol 95(2):299–311
Kolind K, Leong KW, Besenbacher F, Foss M (2012) Guidance of stem cell fate on 2D patterned surfaces. Biomaterials 33(28):6626–6633
Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll HP, e-Cypher Investigators (2006) Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113(11):1434–1441
Zilberman M, Elsner JJ (2008) Antibiotic-eluting medical devices for various applications. J Control Release 130(3):202–215
Those 2012 data are based on the Global Observatory on Donation and Transplantation (GODT) data, produced by the WHO-ONT collaboration
Buckley RH (2003) Transplantation immunology: organ and bone marrow. J Allergy Clin Immunol 111(2 Suppl):S733–S744
van Heurn E, de Vries EE (2009) Kidney transplantation and donation in children. Pediatr Surg Int 25(5):385–393
Freeman RB, Bernat JL (2012) Ethical issues in organ transplantation. Prog Cardiovasc Dis 55(3):282–289
Fahy GM, Wowk B, Wu J (2006) Cryopreservation of complex systems: the missing link in the regenerative medicine supply chain. Rejuvenation Res 9(2):279–291
The organ procurement and transplantation network. The OPTN Web site offers a wealth of information about transplantation (http://optn.transplant.hrsa.gov)
Burra P, De Bona M (2007) Quality of life following organ transplantation. Transpl Int 20(5):397–409
Timms D (2011) A review of clinical ventricular assist devices. Med Eng Phys 33(9):1041–1047
Milla F, Pinney SP, Anyanwu AC (2012) Indications for heart transplantation in current era of left ventricular assist devices. Mt Sinai J Med 79(3):305–316
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Shin'oka T, Imai Y, Ikada Y (2001) Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344:532–533
Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L, Batrinac A, Repin O, Maliga O, Ciubotaru A, Haverich A (2006) Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114(1 Suppl):I132–I137
Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367(9518):1241–1246
Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, Dickinson SC, Hollander AP, Mantero S, Conconi MT, Birchall MA (2008) Clinical transplantation of a tissue-engineered airway. Lancet 372(9655):2023–2030
Gonfiotti A, Jaus MO, Barale D, Baiguera S, Comin C, Lavorini F, Fontana G, Sibila O, Rombolà G, Jungebluth P, Macchiarini P (2013) The first tissue-engineered airway transplantation: 5-year follow-up results. Lancet 383(9913):238–244
Elliott MJ, De Coppi P, Speggiorin S, Roebuck D, Butler CR, Samuel E, Crowley C, McLaren C, Fierens A, Vondrys D, Cochrane L, Jephson C, Janes S, Beaumont NJ, Cogan T, Bader A, Seifalian AM, Hsuan JJ, Lowdell MW, Birchall MA (2012) Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet 380(9846):994–1000
Ott HC (2012) Engineering tissues for children: building grafts that grow. Lancet 380(9846):957–958
Vogel G (2013) Trachea transplants test the limits. Science 340:266–268
Russell AJ (2014) The end of the beginning for tissue engineering. Lancet 383(9913):193–195
Mannoor MS, Jiang Z, James T, Kong YL, Malatesta KA, Soboyejo WO, Verma N, Gracias DH, McAlpine MC (2013) 3D printed bionic ears. Nano Lett 13(6):2634–2639
Williams DF (2008) One the mechanism of biocompatibility. Biomaterials 29:2941–2953
Williams DF (1987) Definitions in biomaterials. Elsevier, Amsterdam
Elek SD, Conen PE (1957) The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection. Br J Exp Pathol 38(6):573–586
Montanaro L, Speziale P, Campoccia D, Ravaioli S, Cangini I, Pietrocola G, Giannini S, Arciola CR (2011) Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol 6(11):1329–1349
Zimmerli W, Zak O, Vosbeck K (1985) Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 17(3):303–310
Hudetz D, Ursic Hudetz S, Harris LG, Luginbühl R, Friederich NF, Landmann R (2008) Weak effect of metal type and ica genes on staphylococcal infection of titanium and stainless steel implants. Clin Microbiol Infect 14(12):1135–1145
Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152–1158
Zimmerli W, Sendi P (2011) Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol 33:295–306
Götz F (2002) Staphylococcus and biofilms. Mol Microbiol 43(6):1367–1378
Kristian SA, Birkenstock TA, Sauder U, Mack D, Götz F, Landmann R (2008) Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis 197(7):1028–1035
Campoccia D, Montanaro L, Arciola CR (2013) A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 34(34):8533–8554
Ketonis C, Parvizi J, Jones LC (2012) Evolving strategies to prevent implant-associated infections. J Am Acad Orthop Surg 20:478–480
Hook AL, Chang CY, Yang J, Luckett J, Cockayne A, Atkinson S, Mei Y, Bayston R, Irvine DJ, Langer R, Anderson DG, Williams P, Davies MC, Alexander MR (2012) Combinatorial discovery of polymers resistant to bacterial attachment. Nat Biotechnol 30(9):868–875
Hickok NJ, Shapiro IM (2012) Immobilized antibiotics to prevent orthopaedic implant infections. Adv Drug Deliv Rev 64(12):1165–1176
Hetrick EM, Schoenfisch MH (2006) Reducing implant-related infections: active release strategies. Chem Soc Rev 35(9):780–789
Otten H (1986) Domagk and the development of the sulphonamides. J Antimicrob Chemother 17:689–696
Liu H, Zhang L, Shi P, Zou Q, Zuo Y, Li Y (2010) Hydroxyapatite/polyurethane scaffold incorporated with drug-loaded ethyl cellulose microspheres for bone regeneration. J Biomed Mater Res B Appl Biomater 95(1):36–46
Ma T, Shang BC, Tang H, Zhou TH, Xu GL, Li HL, Chen QH, Xu YQ (2011) Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed 22(12):1669–1681
Feng K, Sun H, Bradley MA, Dupler EJ, Giannobile WV, Ma PX (2010) Novel antibacterial nanofibrous PLLA scaffolds. J Control Release 146(3):363–369
Hong Y, Fujimoto K, Hashizume R, Guan J, Stankus JJ, Tobita K, Wagner WR (2008) Generating elastic, biodegradable polyurethane/poly(lactide-co-glycolide) fibrous sheets with controlled antibiotic release via two-stream electrospinning. Biomacromolecules 9(4):1200–1207
Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, Hadjiargyrou M (2004) Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release 98(1):47–56
Teo EY, Ong SY, Chong MS, Zhang Z, Lu J, Moochhala S, Ho B, Teoh SH (2011) Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds. Biomaterials 32(1):279–287
Li H, Ogle H, Jiang B, Hagar M, Li B (2010) Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: a preliminary study on cell responses. J Orthop Res 28(8):992–999
Verreck G, Chun I, Rosenblatt J, Peeters J, Dijck AV, Mensch J, Noppe M, Brewster ME (2003) Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. J Control Release 92(3):349–360
Karbach J, Callaway AS, Willershausen B, Wagner W, Al-Nawas B (2013) Multiple resistance to betalactam antibiotics, azithromycin or moxifloxacin in implant associated bacteria. Clin Lab 59(3–4):381–387
Rams TE, Degener JE, van Winkelhoff AJ (2014) Antibiotic resistance in human peri-implantitis microbiota. Clin Oral Implants Res 25(1):82–90
Rodriguez DJ, Afzal A, Evonich R, Haines DE (2012) The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients. Am J Cardiovasc Dis 2(2):116–122
Nablo BJ, Prichard HL, Butler RD, Klitzman B, Schoenfisch MH (2005) Inhibition of implant-associated infections via nitric oxide release. Biomaterials 26(34):6984–6990
Cao H, Liu X (2010) Silver nanoparticles-modified films versus biomedical device-associated infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(6):670–684
Schierholz JM, Lucas LJ, Rump A, Pulverer G (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40(4):257–262
Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ (2012) Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 12(8):4271–4275
Chernousova S, Epple M (2013) Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed 52:1636–1653
Gravante G, Caruso R, Sorge R, Nicoli F, Gentile P, Cervelli V (2009) Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations. Ann Plast Surg 63(2):201–205
Lo SF, Hayter M, Chang CJ, Hu WY, Lee LL (2008) A systematic review of silver-releasing dressings in the management of infected chronic wounds. J Clin Nurs 17(15):1973–1985
Verbelen J, Hoeksema H, Heyneman A, Pirayesh A, Monstrey S (2014) Aquacel® Ag dressing versus Acticoat™ dressing in partial thickness burns: a prospective, randomized, controlled study in 100 patients. Part 1: Burn wound healing. Burns 40(3):416–427, pii: S0305-4179(13)00230-1
Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD (2004) Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control 32(8):445–450
Lackner P, Beer R, Broessner G, Helbok R, Galiano K, Pleifer C, Pfausler B, Brenneis C, Huck C, Engelhardt K, Obwegeser AA, Schmutzhard E (2008) Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 8(3):360–365
Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B (2007) Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 35(4):1032–1039
Antonelli M, De Pascale G, Ranieri VM, Pelaia P, Tufano R, Piazza O, Zangrillo A, Ferrario A, De Gaetano A, Guaglianone E, Donelli G (2012) Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients. J Hosp Infect 82(2):101–107
Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H (2012) Toxicity of silver nanoparticles—nanoparticle or silver ion? Toxicol Lett 208(3):286–292
Pauksch L, Hartmann S, Rohnke M, Szalay G, Alt V, Schnettler R, Lips KS (2014) Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater 10(1):439–449
Albers CE, Hofstetter W, Siebenrock KA, Landmann R, Klenke FM (2013) In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7(1):30–36
Taglietti A, Arciola CR, D’Agostino A, Dacarro G, Montanaro L, Campoccia D, Cucca L, Vercellino M, Poggi A, Pallavicini P, Visai L (2014) Antibiofilm activity of a monolayer of silver nanoparticles anchored to an amino-silanized glass surface. Biomaterials 35(6):1779–1788
Gordon O, Slenters TV, Brunetto PS, Villaruz AE, Sturdevant DE, Otto M (2010) Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother 54:4208–4218
Wang H, Cheng M, Hu J, Wang C, Xu S, Han CC (2013) Preparation and optimization of silver nanoparticles embedded electrospun membrane for implant associated infections prevention. ACS Appl Mater Interfaces 5(21):11014–11021
Mohiti-Asli M, Pourdeyhimi B, Loboa EG (2014) Novel, silver-ion-releasing nanofibrous scaffolds exhibit excellent antibacterial efficacy without the use of silver nanoparticles. Acta Biomater 10(5):2096–2104, pii: S1742-7061
Sheikh FA, Woo Ju H, Mi Moon B, Jung Park H, Kim JH, Joo Lee O, Hum Park C (2014) Facile and highly efficient approach for the fabrication of multifunctional silk nanofibers containing hydroxyapatite and silver nanoparticles. J Biomed Mater Res A 102(10):3459–3469
Samberg ME, Mente P, He T, King MW, Monteiro-Riviere NA (2013) In vitro biocompatibility and antibacterial efficacy of a degradable poly(l-lactide-co-epsilon-caprolactone) copolymer incorporated with silver nanoparticles. Ann Biomed Eng 42:1482–1493
Cheng H, Li Y, Huo K, Gao B, Xiong W (2013) Long-lasting in vivo and in vitro antibacterial ability of nanostructured titania coating incorporated with silver nanoparticles. J Biomed Mater Res A 102:3488–3499
Mijnendonckx K, Leys N, Mahillon J, Silver S, Van Houdt R (2013) Antimicrobial silver: uses, toxicity and potential for resistance. Biometals 26(4):609–621
Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20(2):86–100
Cobelli N, Scharf B, Crisi GM, Hardin J, Santambrogio L (2011) Mediators of the inflammatory response to joint replacement devices. Nat Rev Rheumatol 7(10):600–608
Maitra R, Clement CC, Scharf B, Crisi GM, Chitta S, Paget D, Purdue PE, Cobelli N, Santambrogio L (2009) Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis. Mol Immunol 47(2–3):175–184
Ingham E, Fisher J (2005) The role of macrophages in osteolysis of total joint replacement. Biomaterials 26(11):1271–1286
Thomas MV, Puleo DA (2011) Infection, inflammation, and bone regeneration: a paradoxical relationship. J Dent Res 90(9):1052–1061
Jayant RD, McShane MJ, Srivastava R (2011) In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression. Int J Pharm 403(1–2):268–275
Vacanti NM, Cheng H, Hill PS, Guerreiro JD, Dang TT, Ma M, Watson S, Hwang NS, Langer R, Anderson DG (2012) Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response. Biomacromolecules 13(10):3031–3038
Rujitanaroj PO, Jao B, Yang J, Wang F, Anderson JM, Wang J, Chew SY, Rujitanaroj PO, Jao B, Yang J, Wang F, Anderson JM, Wang J, Chew SY (2013) Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing. Acta Biomater 9(1):4513–4524
Takahashi H, Wang Y, Grainger DW (2010) Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. J Control Release 147(3):400–407
Weldon CB, Tsui JH, Shankarappa SA, Nguyen VT, Ma M, Anderson DG, Kohane DS (2012) Electrospun drug-eluting sutures for local anesthesia. J Control Release 161(3):903–909
Polikov VS, Tresco PA, Reichert WM (2005) Response of brain tissue to chronically implanted neural electrodes. J Neurosci Methods 148(1):1–18
Yue Z, Moulton SE, Cook M, O'Leary S, Wallace GG (2013) Controlled delivery for neuro-bionic devices. Adv Drug Deliv Rev 65(4):559–569
Mercanzini A, Reddy ST, Velluto D, Colin P, Maillard A, Bensadoun JC, Hubbell JA, Renaud P (2010) Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. J Control Release 145(3):196–202
Kim DH, Martin DC (2006) Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27(15):3031–3037
Li B, McKeague AL (2011) Emerging ideas: interleukin-12 nanocoatings prevent open fracture-associated infections. Clin Orthop Relat Res 469(11):3262–3265
Li B, Jiang B, Boyce BM, Lindsey BA (2009) Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections. Biomaterials 30(13):2552–2558
Li B, Jiang B, Dietz MJ, Smith ES, Clovis NB, Rao KM (2010) Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures. J Orthop Res 28(1):48–54
Kolios G, Moodley Y (2013) Introduction to stem cells and regenerative medicine. Respiration 85(1):3–10
Tomisa AP, Launey ME, Lee JS, Mankani MH, Wegst UG, Saiz E (2011) Nanotechnology approaches to improve dental implants. Int J Oral Maxillofac Implants 26(Suppl):25–44, discussion 45–49
Luginbuehl V, Meinel L, Merkle HP, Gander B (2004) Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58(2):197–208
Yoon SJ, Park KS, Kim MS, Rhee JM, Khang G, Lee HB (2007) Repair of diaphyseal bone defects with calcitriol-loaded PLGA scaffolds and marrow stromal cells. Tissue Eng 13(5):1125–1133
Storrie H, Mooney DJ (2006) Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev 58(4):500–514
Andersen MØ, Dillschneider P, Kjems J (2013) The role of MicroRNAs in natural tissue development and application in regenerative medicine. In: RNA interference from biology to therapeutics. Advances in delivery science and technology, vol 15. Springer, New York, pp 57–78
Andersen MØ, Kjems J (2011) RNA interference enhanced implants. In: Active implants and scaffolds for tissue regeneration. Studies in mechanobiology, tissue engineering and biomaterials, vol 8. Springer, New York, pp 145–165
Wadagaki R, Mizuno D, Yamawaki-Ogata A, Satake M, Kaneko H, Hagiwara S, Yamamoto N, Narita Y, Hibi H, Ueda M (2011) Osteogenic induction of bone marrow-derived stromal cells on simvastatin-releasing, biodegradable, nano- to microscale fiber scaffolds. Ann Biomed Eng 39(7):1872–1881
Shah NJ, Hyder MN, Moskowitz JS, Quadir MA, Morton SW, Seeherman HJ, Padera RF, Spector M, Hammond PT (2013) Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings. Sci Transl Med 5(191):191ra83
Nie H, Wang CH (2007) Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release 120(1–2):111–121
Zhao J, Zhang N, Prestwich GD, Wen X (2008) Recruitment of endogenous stem cells for tissue repair. Macromol Biosci 8(9):836–842
Li X, Liu X, Zhao W, Wen X, Zhang N (2012) Manipulating neural-stem-cell mobilization and migration in vitro. Acta Biomater 8(6):2087–2095
Radisic M, Malda J, Epping E, Geng W, Langer R, Vunjak-Novakovic G (2006) Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93(2):332–343
Wittenborn T, Nielsen T, Nygaard JV, Larsen EK, Thim T, Rydtoft LM, Vorup-Jensen T, Kjems J, Nielsen NC, Horsman MR, Falk E (2012) Ultrahigh-field DCE-MRI of angiogenesis in a novel angiogenesis mouse model. J Magn Reson Imaging 35(3):703–710
Nelson CE, Kim AJ, Adolph EJ, Gupta MK, Yu F, Hocking KM, Davidson JM, Guelcher SA, Duvall CL (2014) Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo. Adv Mater 26(4):607–614
Wadee A, Pillay V, Choonara YE, du Toit LC, Penny C, Ndesendo VM, Kumar P, Murphy CS (2011) Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors. Expert Opin Drug Deliv 8(10):1323–1340
Xie J, Wang CH (2006) Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res 23(8):1817–1826
Yohe ST, Herrera VL, Colson YL, Grinstaff MW (2012) 3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells. J Control Release 162(1):92–101
Calışkan N, Bayram C, Erdal E, Karahaliloğlu Z, Denkbaş EB (2014) Titania nanotubes with adjustable dimensions for drug reservoir sites and enhanced cell adhesion. Mater Sci Eng C Mater Biol Appl 35:100–105
Yarin AL (2011) Coaxial electrospinning and emulsion electrospinning of core-shell fibers. Polym Adv Technol 22(3):310–317
Korehei R, Kadla JF (2014) Encapsulation of T4 bacteriophage in electrospun poly(ethylene oxide)/cellulose diacetate fibers. Carbohydr Polym 100:150–157
Zhao L, Chu PK, Zhang Y, Wu Z (2009) Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 91(1):470–480
Wenke JC, Guelcher SA (2011) Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures. Expert Opin Drug Deliv 8(12):1555–1569
Chen FM, Zhang M, Wu ZF (2010) Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31(24):6279–6308
Chen M, Andersen MØ, Dillschneider P, Chang C-C, Gao S, Le DQS, Yang C, Hein S, Bünger C, Kjems J (2015) Co-delivery of siRNA and doxorubicin to cancer cells from additively manufactured implants. RSC Adv 5:101718–101725
Zheng Z, Yin W, Zara JN, Li W, Kwak J, Mamidi R, Lee M, Siu RK, Ngo R, Wang J, Carpenter D, Zhang X, Wu B, Ting K, Soo C (2010) The use of BMP-2 coupled—nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials 31(35):9293–9300
Stevanović M, Uskoković V, Filipović M, Škapin SD, Uskoković D (2013) Composite PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive, antioxidative, and antimicrobial activities. ACS Appl Mater Interfaces 5(18):9034–9042
He S, Xia T, Wang H, Wei L, Luo X, Li X (2012) Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels. Acta Biomater 8(7):2659–2669
Clark A, Milbrandt TA, Hilt JZ, Puleo DA (2014) Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen. Acta Biomater 10(5):2125–2132. doi:10.1016/j.actbio.2013.12.061, pii: S1742-7061(14)00011-7
Min J, Braatz RD, Hammond PT (2014) Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier. Biomaterials 35(8):2507–2517
Shah NJ, Macdonald ML, Beben YM, Padera RF, Samuel RE, Hammond PT (2011) Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 32(26):6183–6193
Basmanav FB, Kose GT, Hasirci V (2008) Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 29(31):4195–4204
Yilgor P, Sousa RA, Reis RL, Hasirci N, Hasirci V (2010) Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration. J Mater Sci Mater Med 21(11):2999–3008
Yilgor P, Hasirci N, Hasirci V (2010) Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A 93(2):528–536
Yilgor P, Tuzlakoglu K, Reis RL, Hasirci N, Hasirci V (2009) Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 30(21):3551–3559
Sheehy EJ, Vinardell T, Buckley CT, Kelly DJ (2013) Engineering osteochondral constructs through spatial regulation of endochondral ossification. Acta Biomater 9(3):5484–5492
Keeney M, Pandit A (2009) The osteochondral junction and its repair via bi-phasic tissue engineering scaffolds. Tissue Eng Part B Rev 15(1):55–73
Cook JL, Kuroki K, Bozynski CC, Stoker AM, Pfeiffer FM, Cook CR (2014) Evaluation of synthetic osteochondral implants. J Knee Surg 27(4):295–302
Kon E, Filardo G, Robinson D, Eisman JA, Levy A, Zaslav K, Shani J, Altschuler N (2014) Osteochondral regeneration using a novel aragonite-hyaluronate bi-phasic scaffold in a goat model. Knee Surg Sports Traumatol Arthrosc 22(6):1452–1464
Filardo G, Kon E, Di Martino A, Busacca M, Altadonna G, Marcacci M (2013) Treatment of knee osteochondritis dissecans with a cell-free biomimetic osteochondral scaffold: clinical and imaging evaluation at 2-year follow-up. Am J Sports Med 41(8):1786–1793
Schleicher I, Lips KS, Sommer U, Schappat I, Martin AP, Szalay G, Hartmann S, Schnettler R (2013) Biphasic scaffolds for repair of deep osteochondral defects in a sheep model. J Surg Res 183(1):184–192
Wang X, Wenk E, Zhang X, Meinel L, Vunjak-Novakovic G, Kaplan DL (2009) Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134(2):81–90
Dormer NH, Singh M, Zhao L, Mohan N, Berkland CJ, Detamore MS (2012) Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals. J Biomed Mater Res A 100(1):162–170
Mohan N, Dormer NH, Caldwell KL, Key VH, Berkland CJ, Detamore MS (2011) Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface. Tissue Eng Part A 17(21–22):2845–2855
Andersen MØ, Nygaard JV, Burns JS, Raarup MK, Nyengaard JR, Bünger C, Besenbacher F, Howard KA, Kassem M, Kjems J (2010) siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. Mol Ther 18(11):2018–2027
Melchels FPW, Domingos MAN, Klein TJ, Malda J, Bartolo PJ, Hutmacher DW (2012) Additive manufacturing of tissues and organs. Prog Polym Sci 37(8):1079–1104
Xu T, Zhao W, Zhu JM, Albanna MZ, Yoo JJ, Atala A (2013) Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials 34(1):130–139
Jakab K, Norotte C, Marga F, Murphy K, Vunjak-Novakovic G, Forgacs G (2010) Tissue engineering by self-assembly and bio-printing of living cells. Biofabrication 2(2):022001
Kolesky DB, Truby RL, Gladman AS, Busbee TA, Homan KA, Lewis JA (2014) 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater 26(19):3124–3130
Lee JS, Hong JM, Jung JW, Shim JH, Oh JH, Cho DW (2014) 3D printing of composite tissue with complex shape applied to ear regeneration. Biofabrication 6(2):024103
Andersen MØ et al (2013) Spatially controlled delivery of siRNAs to stem cells in implants generated by multi-component additive manufacturing. Adv Funct Mater 23(45):5599–5607
Xu T, Rohozinski J, Zhao W, Moorefield EC, Atala A, Yoo JJ (2009) Inkjet-mediated gene transfection into living cells combined with targeted delivery. Tissue Eng Part A 15(1):95–101
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Controlled Release Society
About this chapter
Cite this chapter
Andersen, M.Ø. (2016). The Application of Nanotechnology for Implant Drug Release. In: Howard, K., Vorup-Jensen, T., Peer, D. (eds) Nanomedicine. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3634-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3634-2_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3632-8
Online ISBN: 978-1-4939-3634-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)